ArticleScientific reports2025
The RNA-binding protein CPEB1 marks healthy adult β cells in mice but is dispensable for β cell identity and function.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genome-wide cell type-specific and sex-specific transcriptional dysregulation in the islet of Langerhans underlies islet dysfunction in Down syndrome-related diabetes.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
RNA binding proteins (RBPs) are increasingly being recognized as important regulators of pancreatic β cells' identity and function. We identified the poly-A binding RBP, CPEB1, as a potential new regulator linked to β cell failure in diabetes based on its enrichment in mature, healthy adult β cells and its sharp decrease in β cells in type 1 diabetes (T1D) and type 2 diabetes (T2D). While CPEB1 is known to regulate an extensive range of biological processes, and its involvement in regulating genes involved in insulin signaling and apoptosis in the liver has been reported, CPEB1 function in β cells is unknown. Here, we have used two independent genetic mouse models, namely β cell-specific and whole body Cpeb1 deletions, to assess the role of CPEB1 in β cells. We show that CPEB1 is dispensable for β cell function and identity. Using bulk RNA sequencing on islets of both models, we also show that CPEB1 regulates markedly different sets of genes between islets of male and female mice, both at the transcriptional and at the polyadenylation levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.